Nixon Peabody
Premier Valley
You are here:  Home  >  Biotech  >  Current Article

Making an ImmPACT: New firm raises $18M to pursue T-cell therapies

By   /   Friday, August 28th, 2020  /   No Comments

    Print       Email
Camarillo startup ImmPACT Bio is joining the pursuit for T-cell immunotherapies with $18 million in its pocket. The company is setting up shop in a Southern California hotbed for the avenue of research, which seeks to treat solid tumors using patients’ own immune cells. That includes efforts from regional heavyweight Amgen and Thousand Oaks-based Atara…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

Henry Dubroff

Don’t let election jitters rattle your faith in stocks, experts say

Read More →